A detailed history of Jane Street Group, LLC transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Jane Street Group, LLC holds 15,684 shares of TLSA stock, worth $14,429. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,684
Holding current value
$14,429
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$0.67 - $1.18 $10,508 - $18,507
15,684 New
15,684 $10,000
Q2 2023

Aug 14, 2023

BUY
$0.65 - $1.29 $8,431 - $16,732
12,971 New
12,971 $8,000
Q3 2022

Nov 14, 2022

BUY
$0.55 - $0.83 $5,576 - $8,415
10,139 New
10,139 $8,000
Q1 2022

May 17, 2022

SELL
$0.62 - $1.25 $30,652 - $61,798
-49,439 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$0.89 - $1.66 $44,000 - $82,068
49,439 New
49,439 $47,000

Others Institutions Holding TLSA

About Tiziana Life Sciences Ltd


  • Ticker TLSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,273,000
  • Market Cap $94.1M
  • Description
  • Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...
More about TLSA
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.